31 – 40 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Vaccines and allergic reactions : The past, the current COVID-19 pandemic, and future perspectives
(
- Contribution to journal › Scientific review
-
Mark
Immune modulation via T regulatory cell enhancement : Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
(
- Contribution to journal › Article
-
Mark
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025 : Results from Two Randomized Studies in Healthy Subjects
(
- Contribution to journal › Article
-
Mark
Allergen bronchoprovocation test : an important research tool supporting precision medicine
(
- Contribution to journal › Article
-
Mark
Editorial : Dealing with asthma during the turbulent times of coronavirus disease-2019
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Revisiting matrix metalloproteinase 12 : its role in pathophysiology of asthma and related pulmonary diseases
(
- Contribution to journal › Article
-
Mark
Asthma and severe acute respiratory syndrome coronavirus 2019 : current evidence and knowledge gaps
(
- Contribution to journal › Article
-
Mark
Use of fractional exhaled nitric oxide to guide the treatment of asthma an official american thoracic society clinical practice guideline
(
- Contribution to journal › Article
- 2020
-
Mark
Editorial : Asthma: a modifiable disease on a crossroad
(
- Contribution to journal › Article
-
Mark
Real-life assessment of chronic rhinosinusitis patients using mobile technology : The mySinusitisCoach project by EUFOREA
(
- Contribution to journal › Article